Beckman Coulter Acquired by Danaher as In Vitro Diagnostics Industry Consolidates

Clinical pathology laboratory customers of Beckman Coulter shouldn’t see major changes Yesterday came news that Danaher Corporation (NYSE: DHR) of Washington, D.C., would acquire Beckman Coulter, Inc., (NYSE: BEC) of Brea, California, in a transaction valued at $6.8 billion. Beckman is among the world’s larger manufacturers of in vitro diagnostics (IVD) analyzers and automation for clinical pathology laboratories. For pathologists and medical laboratory administrators, the significance of the...
;